Scienture Holdings (SCNX) EBITDA Margin Growth (3y) (2016 - 2026)
Powered by 
Analysis
Scienture Holdings (SCNX) EBITDA Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 1,129.00 |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -925.00 |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -2,128.00 |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 293.00 |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 693.00 |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 457.00 |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -230,408.00 |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -372.00 |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 15,005.00 |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | -62,199.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -62,199.00 |
| Mar 31, 2026 | -606,740.00 |
| Mar 31, 2025 | -3.48 Mn |
| Jun 30, 2024 | -786,341.00 |
| Dec 31, 2023 | 18,860.00 |
| Sep 30, 2023 | -4,337.00 |
| Jun 30, 2023 | -15,552.00 |
| Mar 31, 2023 | -17,195.00 |
| Dec 31, 2022 | -5,336.00 |
| Sep 30, 2022 | -1,834.00 |
| Jun 30, 2022 | -4,057.00 |
| Mar 31, 2022 | -4,125.00 |
| Dec 31, 2021 | -883.00 |
| Sep 30, 2021 | -6,166.00 |
| Jun 30, 2021 | -13,912.00 |
| Mar 31, 2021 | -3,268.00 |
| Dec 31, 2020 | -13,589.00 |
| Sep 30, 2020 | -988.00 |
| Jun 30, 2020 | -1,504.00 |
| Mar 31, 2020 | -1,042.00 |